- Home
- KRC vs ACLX Comparison
KRC vs ACLX Comparison
Compare KRC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRC
- ACLX
- Stock Information
- Founded
- KRC 1947
- ACLX 2015
- Country
- KRC United States
- ACLX United States
- Employees
- KRC N/A
- ACLX N/A
- Industry
- KRC Real Estate Investment Trusts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- KRC Real Estate
- ACLX Health Care
- Exchange
- KRC Nasdaq
- ACLX Nasdaq
- Market Cap
- KRC N/A
- ACLX 3.5B
- IPO Year
- KRC 1997
- ACLX 2022
- Fundamental
- Price
- KRC $34.55
- ACLX $65.55
- Analyst Decision
- KRC Hold
- ACLX Strong Buy
- Analyst Count
- KRC 10
- ACLX 14
- Target Price
- KRC $38.90
- ACLX $111.42
- AVG Volume (30 Days)
- KRC 1.2M
- ACLX 552.8K
- Earning Date
- KRC 07-28-2025
- ACLX 08-07-2025
- Dividend Yield
- KRC 6.12%
- ACLX N/A
- EPS Growth
- KRC N/A
- ACLX N/A
- EPS
- KRC 1.68
- ACLX N/A
- Revenue
- KRC $1,127,892,000.00
- ACLX $76,809,000.00
- Revenue This Year
- KRC N/A
- ACLX N/A
- Revenue Next Year
- KRC $1.81
- ACLX $112.68
- P/E Ratio
- KRC $21.01
- ACLX N/A
- Revenue Growth
- KRC 1.11
- ACLX N/A
- 52 Week Low
- KRC $27.07
- ACLX $47.86
- 52 Week High
- KRC $43.78
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- KRC 52.06
- ACLX 53.46
- Support Level
- KRC $33.69
- ACLX $63.13
- Resistance Level
- KRC $35.36
- ACLX $67.83
- Average True Range (ATR)
- KRC 0.88
- ACLX 2.52
- MACD
- KRC -0.12
- ACLX 0.09
- Stochastic Oscillator
- KRC 33.85
- ACLX 67.00
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.